Deflazacort

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 546 publications

Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.

Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.

Journal: Neurology

Published: May 27, 2026

Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.

Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.

Journal: Drug research

Published: May 12, 2026

Successful Management of a Chronic Pedal Ulcer Secondary to Snake Bite: A Case Report.

Successful Management of a Chronic Pedal Ulcer Secondary to Snake Bite: A Case Report.

Journal: Cureus

Published: February 24, 2026

Elimination Profile of Deflazacort and Metabolites in Urine and Plasma Following Oral Administration: Relevance to Sports Drug Testing.

Elimination Profile of Deflazacort and Metabolites in Urine and Plasma Following Oral Administration: Relevance to Sports Drug Testing.

Journal: Drug testing and analysis

Published: February 12, 2026

From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians.

From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians.

Journal: Neuromuscular disorders : NMD

Published: February 02, 2026

Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in Spain.

Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in Spain.

Journal: Neurology and therapy

Published: December 30, 2025

Low-dose deflazacort reduces postoperative pain and inflammation following primary total knee arthroplasty: A randomized controlled trial.

Low-dose deflazacort reduces postoperative pain and inflammation following primary total knee arthroplasty: A randomized controlled trial.

Journal: Journal of ISAKOS : joint disorders & orthopaedic sports medicine

Published: December 30, 2025

A Rare Co-occurrence of Duchenne Muscular Dystrophy and Glycerol Kinase Deficiency Associated With Xp21 Contiguous Gene Deletion Syndrome: A Case Report.

A Rare Co-occurrence of Duchenne Muscular Dystrophy and Glycerol Kinase Deficiency Associated With Xp21 Contiguous Gene Deletion Syndrome: A Case Report.

Journal: Cureus

Published: December 24, 2025

Corticosteroid treatment in Duchenne muscular dystrophy.

Corticosteroid treatment in Duchenne muscular dystrophy.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Published: December 14, 2025

State of art of oral corticosteroids in children with acute asthma and wheezing.

State of art of oral corticosteroids in children with acute asthma and wheezing.

Journal: Italian journal of pediatrics

Published: November 12, 2025

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.

Journal: Journal of neurology

Published: November 11, 2025

Paper-based reaction devices as accelerated platforms in forced degradation studies.

Paper-based reaction devices as accelerated platforms in forced degradation studies.

Journal: Journal of pharmaceutical sciences

Published: September 29, 2025

Showing 1-12 of 546

Last Updated: 06/30/2026